Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Xarelto (rivaroxaban) prevents dangerous clots, but its most common side effect is bleeding that can range from minor bruising and nosebleeds to life-threatening hemorrhage. Warning signs that need urgent care include bleeding that will not stop, pink, red, or brown urine, black or bloody stools, vomit that looks like coffee grounds, coughing up blood, unusual bruising, severe headache, sudden dizziness or weakness, vision changes, and any head injury even without visible bleeding. Back pain, numbness, tingling, or muscle weakness after a spinal procedure can signal a spinal hematoma and requires emergency evaluation. Risk rises with older age, kidney problems, stomach ulcers, recent surgery, and combining Xarelto with NSAIDs, aspirin, other blood thinners, or certain antidepressants, and stopping the drug suddenly raises stroke risk, so several factors matter here. See below for the full list of symptoms, timing, and next steps you should consider.
If you are noticing bleeding, bruising, or symptoms that feel off while taking a blood thinner, it helps to sort out what needs an emergency room today versus a call to your prescriber. A free, instant, online symptom check lets you enter your symptoms and medications in a few minutes, then points you toward the level of care that fits your situation so you are not left guessing while a bleed may be developing.
Last reviewed for medical accuracy: 09/28/2026
Xarelto (rivaroxaban) is a prescription blood thinner commonly used to reduce the risk of stroke and treat or prevent dangerous blood clots. Like all anticoagulants, Xarelto carries certain risks—most notably bleeding. Understanding the possible xarelto side effects, recognizing warning signs and knowing when to seek help can keep you safer and more informed about your treatment.
Xarelto blocks a key clotting protein (factor Xa), slowing your blood’s ability to form clots. That helps prevent strokes in people with atrial fibrillation and treats deep vein thrombosis (DVT) or pulmonary embolism (PE). But because it thins the blood, even small injuries can lead to more bleeding than usual.
Many people tolerate Xarelto well, with mild side effects that often improve over time. Common xarelto side effects include:
If these effects are minor and short-lived, they typically don’t require urgent care. Still, always mention them to your doctor at your next visit.
Bleeding is the most serious side effect of Xarelto. It can range from minor to life-threatening. Factors that increase your bleeding risk include:
Your doctor should review all your medications, supplements and health conditions before you start Xarelto.
While minor bleeding can be annoying, it usually isn’t dangerous. You can manage many of these at home and discuss them at your next medical appointment.
Major bleeding requires immediate medical attention. Signs include:
If you notice any of these, call 911 or go to the nearest emergency department. These could be signs of internal bleeding.
Prompt action can be lifesaving. Seek urgent care if you experience:
If you’re unsure how serious your symptoms are, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide whether you need emergency care or a scheduled doctor visit: https://ubiehealth.com/
You can take steps to reduce the chance of bleeding on Xarelto:
Medication Management
Protect Yourself from Injury
Monitor Health Conditions
Lifestyle Choices
Even if your bleeding seems minor, mention it at your next appointment. Tell your provider about:
Your doctor may adjust your dose, recommend additional tests or switch you to a different blood thinner.
Xarelto is highly effective at preventing and treating dangerous blood clots, but it carries a risk of bleeding. Knowing the common xarelto side effects, identifying warning signs of serious bleeding and taking preventive steps can help you stay safe. If you ever feel unsure about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker: https://ubiehealth.com/. And remember, if you experience any life-threatening or serious symptoms, speak to a doctor or go to the nearest emergency department right away. Always keep your healthcare team informed so they can guide you to the safest and most effective treatment plan.
(References)
* Amin A, Keshishian A, Trocio J, Dina O, Le H, Rosenblatt L, Liu X, Mardekian J, Zhang Q, Baser O, Vo L. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population. Curr Med Res Opin. 2017 Sep;33(9):1595-1604. doi: 10.1080/03007995.2017.1345729. Epub 2017 Jul 11. PMID: 28635338.
* Proietti M, Romanazzi I, Romiti GF, Farcomeni A, Lip GYH. Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22. PMID: 29167388.
* Andersson NW, Svanström H, Lund M, Pasternak B, Melbye M. Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation. Int J Cardiol. 2018 Oct 1;268:113-119. doi: 10.1016/j.ijcard.2018.03.047. Epub 2018 Jun 20. PMID: 29934230.
* Holt A, Strange JE, Rasmussen PV, Blanche P, Nouhravesh N, Jensen MH, Schjerning AM, Schou M, Torp-Pedersen C, Gislason GH, Hansen ML, McGettigan P, Lamberts M. Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran. Am J Med. 2022 May;135(5):595-602.e5. doi: 10.1016/j.amjmed.2021.11.008. Epub 2021 Nov 30. PMID: 34861201.
* Dawwas GK, Leonard CE, Lewis JD, Cuker A. Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. Ann Intern Med. 2022 Jan;175(1):20-28. doi: 10.7326/M21-0717. Epub 2021 Dec 7. PMID: 34871048.
* Chowdhury KR, Michaud J, Yu OHY, Yin H, Azoulay L, Renoux C. Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus. Thromb Haemost. 2022 Oct;122(10):1794-1803. doi: 10.1055/a-1798-2116. Epub 2022 Mar 15. PMID: 35292949.
* Aslan O, Yıldırım S. Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data. Turk J Med Sci. 2022 Aug;52(4):948-957. doi: 10.55730/1300-0144.5395. Epub 2022 Aug 10. PMID: 36326404; PMCID: PMC10387864.
* Chen G, Chen J, Zhao Q, Zhu Y. Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation. Drug Des Devel Ther. 2024;18:1573-1582. doi: 10.2147/DDDT.S459658. Epub 2024 May 13. PMID: 38765878; PMCID: PMC11100512.
* Dawwas GK, Cuker A. Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria. J Thromb Haemost. 2025 Feb;23(2):546-555. doi: 10.1016/j.jtha.2024.10.009. Epub 2024 Oct 21. PMID: 39442621; PMCID: PMC12207736.
* Tanoğlu C, Ersoy A. Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis. BMC Neurol. 2025 Jul 17;25(1):294. doi: 10.1186/s12883-025-04306-1. Epub 2025 Jul 17. PMID: 40676530; PMCID: PMC12272959.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.